Studies have shown that SGLT2-Is not onlysignificantly improves the cardiovascular and renal health of patients with T2DM,but also has positive therapeutic effects in non-diabetic individuals with orwithout HF [5, 6, 7]. This evidence concerns the gene SLC5A2 and hydrops fetalis.